119 related articles for article (PubMed ID: 6105809)
1. Chronic neuroleptic treatment and dopamine receptor regulation.
Creese I; Snyder SH
Adv Biochem Psychopharmacol; 1980; 24():89-94. PubMed ID: 6105809
[No Abstract] [Full Text] [Related]
2. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic drugs and their action on different neuronal pathways.
Ungerstedt U; Herrera-Marschitz M; Forster C
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
[TBL] [Abstract][Full Text] [Related]
4. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
Jenner P; Marsden CD
Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
[No Abstract] [Full Text] [Related]
5. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
Costentin J
Encephale; 1979; 5(2):121-49. PubMed ID: 38958
[TBL] [Abstract][Full Text] [Related]
6. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
7. Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.
Waddington JL; Cross AJ; Gamble SJ; Bourne RC
Adv Biochem Psychopharmacol; 1983; 37():299-308. PubMed ID: 6138952
[No Abstract] [Full Text] [Related]
8. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
[No Abstract] [Full Text] [Related]
9. [Chronology of the extrapyramidal effects of neuroleptics, and the nigrostriatal dopaminergic system].
Petit M; Lepine JP; Lesieur P
Encephale; 1979; 5(4):297-316. PubMed ID: 42527
[TBL] [Abstract][Full Text] [Related]
10. [The receptor-binding profile of neuroleptic agents].
Eneman M
TVZ; 1990 Feb; (3):89-93. PubMed ID: 1969274
[No Abstract] [Full Text] [Related]
11. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
[No Abstract] [Full Text] [Related]
12. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
Schweitzer JW; Schwartz R; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
Clement-Cormier Y
Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
[No Abstract] [Full Text] [Related]
14. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
Hyttel J
Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
[No Abstract] [Full Text] [Related]
15. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
Płaźnik A; Kostowski W
Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
[No Abstract] [Full Text] [Related]
16. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
Belmaker RH; Dasberg H; Ebstein RP
Prog Biochem Pharmacol; 1980; 16():109-18. PubMed ID: 6108567
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Bitton V; Melamed E
J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
[TBL] [Abstract][Full Text] [Related]
18. Molindone hydrochloride: a review of laboratory and clinical findings.
Owen RR; Cole JO
J Clin Psychopharmacol; 1989 Aug; 9(4):268-76. PubMed ID: 2671060
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic/dopamine receptors: elevation and reversal.
List S; Seeman P
Adv Biochem Psychopharmacol; 1980; 24():95-101. PubMed ID: 6105811
[No Abstract] [Full Text] [Related]
20. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
